Hollings celebrates getting its first Stand Up to Cancer grant. Leading the study at Hollings are Marvella Ford, Ph.D., and Gerard Silvestri, M.D. They are part of a team recently awarded a $3 million grant that will make Hollings a part of the Southeastern Consortium for Lung Cancer Health Equity (SC3), a group that will focus on why lung cancer continues to be one of the leading causes of death among racially and ethnically diverse populations in the nation. 

The project is a collaboration among Hollings, UNC Lineberger Comprehensive Cancer Center and VCU Massey Cancer Center.

Hollings launched its new community health van in Cherokee County, South Carolina. The van provided HPV vaccinations to middle schoolers. It's one way Hollings is hoping to increase vaccination rates.

Hollings researchers were also part of a recent study that looked at ways to combat HPV vaccine misinformation by creating vaccine 'champions.'

Graham Warren, M.D., Ph.D., worked with the American College of Surgeons’ Commission on Cancer (CoC) to develop a smoking cessation study for cancer care centers across the country.

The project, titled “Just ASK,” requires cancer center staff to ask new cancer patients if they smoke and encourages them to help their patients to quit smoking.

Leonardo Ferreira, Ph.D., is studying the complex functions of T-cell subsets in anti-cancer and immune tolerance applications. The goal is to lead to the design and development of new immune cell-based therapies.

Ferreira's opinion article was published in Frontiers of Immunology and highlights a weakness in the current CAR-T-cell design.

The standard of care for multiple myeloma patients after a transplant is to remain on maintenance chemotherapy for the rest of their lives, as long as they tolerate and respond well to it.

Glenn Bachmann is participating in a phase III clinical trial at Hollings that is testing whether a new approach could eliminate the need for maintenance chemotherapy after about two years for patients in deep remission.

Got news? We have outlets, from our news site to our video boards! We’d love to help promote your latest journal publications, grants, clinical advances, awards, events and patient stories. Please contact the Hollings communications team to share your news or if you have questions.

Know someone who might be interested in receiving the latest cancer stories and research in their inbox? Forward this email to a friend!

Explore some of our featured trials being offered at Hollings.

Check out the latest publications from doctors and researchers at Hollings.